http://purl.org/np/RAHJOTpJkx... RAHJOTpJkx

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#wasAttributedTo wasAttributedTo

https://orcid.org/0000-0002-3668-2627 Elif Ozkan

Elif Ozkan

2022-10-13T12:29:39.252Z

http://purl.org/np/RAHJOTpJkx... RAHJOTpJkx

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#generatedAtTime generatedAtTime

2022-10-13T12:29:39.252703

Elif Ozkan

2022-10-13T12:29:39.252Z

http://purl.org/np/RAHJOTpJkx... RAHJOTpJkx

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#wasQuotedFrom wasQuotedFrom

Invirase in combination with ritonavir and other antiretroviral agents is indicated for the treatment of HIV-1 infection in adults (over the age of 16 years) in adults. InvirASE is indicated to be an effective form of treatment for adults over the ages of 16. In addition to other anti-HIV-1 agents, INVIRASE is also indicated for adults with age 16-years-old HIV infection.

Elif Ozkan

2022-10-13T12:29:39.252Z